Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Outpatient pediatric neurosurgery.

J R Mawk1, K R Peters, C Borg

  • 1Department of Surgery (Neurosurgery), University of Nebraska Medical Center, Omaha 68105-1065.

Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery
|February 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regorafenib and metronomic capecitabine, cyclophosphamide, and aspirin in refractory metastatic colorectal cancer: results from the REPROGRAM-01 single-arm phase II trial.

ESMO gastrointestinal oncology·2026
Same author

Concomitant proton pump inhibitors and capecitabine-based chemoradiotherapy in rectal cancer: an ancillary study from the PRODIGE 23 trial.

ESMO gastrointestinal oncology·2026
Same author

Authors' reply to the Letters to the Editor discussing main outcomes of the PRODIGE 23 study.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

The presence of senescent peripheral T-cells is negatively correlated to COVID-19 vaccine-induced immunity in cancer patients under 70 years of age.

Frontiers in immunology·2023
Same author

First-line trifluridine/tipiracil + bevacizumab in patients with unresectable metastatic colorectal cancer: final survival analysis in the TASCO1 study.

British journal of cancer·2022

Outpatient neurosurgery for children is safe and cost-effective. This study found significant hospital charge savings, demonstrating the viability of same-day surgical procedures for pediatric neurosurgical patients.

Area of Science:

  • Pediatric Neurosurgery
  • Health Services Research
  • Surgical Outcomes

Background:

  • Evaluating the safety and cost-effectiveness of outpatient neurosurgical procedures in pediatric populations.
  • Assessing anesthetic and surgical complication rates in children undergoing same-day surgery.
  • Quantifying potential hospital cost reductions associated with outpatient neurosurgical interventions.

Observation:

  • Thirty-one pediatric patients underwent various neurosurgical operations on an outpatient basis over 16 months.
  • No anesthetic complications were reported among the study cohort.
  • One patient required a brief hospital admission for a surgical complication, with full recovery.

Findings:

  • Outpatient surgery in a dedicated surgical facility resulted in a minimum 49.5% reduction in hospital charges.

Related Experiment Videos

  • Utilizing the main hospital operating suite for outpatient procedures yielded a 19.8% cost reduction.
  • Pediatric neurosurgical procedures demonstrated a high safety profile in the outpatient setting.
  • Implications:

    • Outpatient neurosurgery is a safe and economically beneficial approach for pediatric patients.
    • Implementing outpatient protocols can lead to substantial savings in healthcare expenditures.
    • This model supports increased accessibility and efficiency in pediatric neurosurgical care.